Differential effect of pioglitazone (PGZ) and rosiglitazone (RGZ) on postprandial glucose and lipid metabolism in patients with type 2 diabetes mellitus: a prospective, randomized crossover study

Chappuis, Bernard; Braun, Monika; Stettler, Christoph; Allemann, Sabine; Diem, Peter; Lumb, Peter J; Wierzbicki, Anthony S; James, Richard; Christ, Emanuel R (2007). Differential effect of pioglitazone (PGZ) and rosiglitazone (RGZ) on postprandial glucose and lipid metabolism in patients with type 2 diabetes mellitus: a prospective, randomized crossover study. Diabetes, metabolism research and reviews, 23(5), pp. 392-9. Chichester: John Wiley & Sons 10.1002/dmrr.715

Full text not available from this repository. (Request a copy)

Postprandial metabolism is impaired in patients with type 2 diabetes (T2Dm). Two thiazolidinediones pioglitazone (PGZ) and rosiglitazone (RGZ) have similar effects on glycaemic control but differ in their effects on fasting lipids. This study investigated the effects of RGZ and PGZ on postprandial metabolism in a prospective, randomized crossover trial.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Gynaecology, Paediatrics and Endocrinology (DFKE) > Clinic of Endocrinology, Diabetology and Clinical Nutrition
04 Faculty of Medicine > Pre-clinic Human Medicine > Institute of Social and Preventive Medicine

UniBE Contributor:

Stettler, Christoph; Allemann, Sabin; Diem, Peter and Christ, Emanuel

ISSN:

1520-7552

ISBN:

17211855

Publisher:

John Wiley & Sons

Language:

English

Submitter:

Factscience Import

Date Deposited:

04 Oct 2013 14:53

Last Modified:

06 Dec 2013 13:45

Publisher DOI:

10.1002/dmrr.715

PubMed ID:

17211855

Web of Science ID:

000248437400008

URI:

https://boris.unibe.ch/id/eprint/22378 (FactScience: 34460)

Actions (login required)

Edit item Edit item
Provide Feedback